Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    ASUBIO
Show Display Options
Rank Status Study
1 Withdrawn Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
Condition: Stroke
Interventions: Drug: SUN13837;   Drug: placebo
2 Completed A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: ASB17061;   Drug: Placebo
3 Terminated Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
Condition: Stroke
Interventions: Drug: piclozotan low dose;   Drug: placebo;   Drug: piclozotan high dose

Indicates status has not been verified in more than two years